Literature DB >> 26890858

The impact of broader regional sharing of livers: 2-year results of "Share 35".

Erick B Edwards1, Ann M Harper1, Ryutaro Hirose2, David C Mulligan3.   

Abstract

In June of 2013, the Organ Procurement and Transplantation Network (OPTN) implemented regional sharing for Model for End-Stage Liver Disease (MELD)/Pediatric End-Stage Liver Disease (PELD) candidates with scores reaching 35 and above ("Share 35"). The goal of this distribution change was to increase access to lifesaving transplants for the sickest candidates with chronic liver disease and to reduce the waiting-list mortality for this medically urgent group of patients. To assess the impact of this change, we compared results before and after policy implementation at 2 years. Overall, there were more liver transplants performed under Share 35 and a greater percentage of MELD/PELD 35+ candidates underwent transplantation; waiting-list mortality rates in this group were also significantly lower in the post-policy period. Overall adjusted waiting-list mortality was decreased slightly, with no significant changes in mortality by age group or ethnicity. Posttransplant graft and patient survival was unchanged overall and was unchanged for the MELD/PELD 35+ recipients. In conclusion, these data demonstrate that the Share 35 policy achieved its goal of increasing access to transplants for these medically urgent patients without reducing access to liver transplants for pediatric and minority candidates. Although the variance in the median MELD at transplant as well as the variance in transport distance increased, there was a decrease in overall liver discard rates and no change in overall cold ischemia times following broader sharing of these organs. The OPTN will continue to monitor this policy, particularly for longer-term posttransplant survival outcomes.
© 2016 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2016        PMID: 26890858     DOI: 10.1002/lt.24418

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  15 in total

1.  Offer acceptance practices and geographic variability in allocation model for end-stage liver disease at transplant.

Authors:  Andrew Wey; Joshua Pyke; David P Schladt; Sommer E Gentry; Tim Weaver; Nicholas Salkowski; Bertram L Kasiske; Ajay K Israni; Jon J Snyder
Journal:  Liver Transpl       Date:  2018-04       Impact factor: 5.799

2.  Outcomes After Resection of Hepatocellular Carcinoma: Intersection of Travel Distance and Hospital Volume.

Authors:  Eliza W Beal; Rittal Mehta; Katiuscha Merath; Diamantis I Tsilimigras; J Madison Hyer; Anghela Paredes; Mary E Dillhoff; Jordan Cloyd; Aslam Ejaz; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2019-05-08       Impact factor: 3.452

3.  Geographic Disparity in Deceased Donor Liver Transplant Rates Following Share 35.

Authors:  Mary G Bowring; Sheng Zhou; Eric K H Chow; Allan B Massie; Dorry L Segev; Sommer E Gentry
Journal:  Transplantation       Date:  2019-10       Impact factor: 4.939

Review 4.  Liver Allocation Policies in the USA: Past, Present, and the Future.

Authors:  Anjana Pillai; Thomas Couri; Michael Charlton
Journal:  Dig Dis Sci       Date:  2019-04       Impact factor: 3.199

5.  Transplanting hepatitis C virus-positive livers into hepatitis C virus-negative patients with preemptive antiviral treatment: A modeling study.

Authors:  Jagpreet Chhatwal; Sumeyye Samur; Emily D Bethea; Turgay Ayer; Fasiha Kanwal; Chin Hur; Mark S Roberts; Norah Terrault; Raymond T Chung
Journal:  Hepatology       Date:  2018-04-19       Impact factor: 17.425

6.  Improved posttransplant mortality after share 35 for liver transplantation.

Authors:  Allison J Kwong; Aparna Goel; Ajitha Mannalithara; W Ray Kim
Journal:  Hepatology       Date:  2017-11-13       Impact factor: 17.425

7.  Waitlist Outcomes of Liver Transplant Candidates Who Were Reprioritized Under Share 35.

Authors:  E K H Chow; A B Massie; X Luo; C E Wickliffe; S E Gentry; A M Cameron; D L Segev
Journal:  Am J Transplant       Date:  2016-08-24       Impact factor: 8.086

8.  Effect of broader geographic sharing of donor lungs on lung transplant waitlist outcomes.

Authors:  Joshua J Mooney; Jay Bhattacharya; Gundeep S Dhillon
Journal:  J Heart Lung Transplant       Date:  2018-09-14       Impact factor: 10.247

9.  Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy.

Authors:  Chiranjeevi Gadiparthi; George Cholankeril; Eric R Yoo; Menghan Hu; Robert J Wong; Aijaz Ahmed
Journal:  Dig Dis Sci       Date:  2018-04-02       Impact factor: 3.199

10.  Predictors of Survival After Liver Transplantation in Patients With the Highest Acuity (MELD ≥40).

Authors:  Michael D Evans; Jessica Diaz; Anna M Adamusiak; Timothy L Pruett; Varvara A Kirchner; Raja Kandaswamy; Vanessa R Humphreville; Thomas M Leventhal; Jeffrey O Grosland; David M Vock; Arthur J Matas; Srinath Chinnakotla
Journal:  Ann Surg       Date:  2020-09-01       Impact factor: 13.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.